Effect of β2‐agonist treatment and spirometry on exhaled nitric oxide in healthy children and children with asthma
- 14 August 2002
- journal article
- diagnostic and-therapeutic-methods
- Published by Wiley in Pediatric Pulmonology
- Vol. 34 (3), 203-208
- https://doi.org/10.1002/ppul.10154
Abstract
We set out to determine the effect of spirometry and bronchodilator therapy on exhaled nitric oxide (FENO) values in children. We hypothesized that there will be no difference on FENO values pre- and postspirometry and following bronchodilator therapy. Sixteen children [(mean = 14.4 ± 1.2 years; range, 12–18 years; healthy controls (n = 6); asthmatics on inhaled steroids (n = 5); and asthmatics on no steroids (n = 5)] had exhaled nitric oxide (FENO) measurements on 4 consecutive days as follows: pre- and postspirometry (day 1); pre- and postalbuterol metered dose inhaler (MDI) therapy (day 2); pre- and postspirometry and albuterol MDI therapy (day 3); and pre- and postspirometry and placebo MDI (day 4). FENO was measured with a chemiluminescence analyzer, using the single vital capacity exhalation technique at an exhalation flow of 50 mL/sec. There were no statistically significant differences in FENO values pre- and poststudy maneuvers under all experimental conditions in healthy children. However, in healthy children, clinically relevant (>10%) differences from baseline were observed on day 1 (3–18 min) and day 4 at 18 min. In children with asthma, FENO values increased significantly by 11–19% from pretreatment levels at 8 and 18 min, postbronchodilator on day 2, and 12–17% at 8 and 18 min post bronchodilator and spirometry on day 3. Spirometry and treatment with a placebo (day 4) resulted in a decrease in FENO values by 11% at 3 min postbaseline in patients on inhaled steroids. The changes observed were similar in children on vs. off inhaled steroids, and also in well-controlled vs. poorly controlled asthma. We conclude that FENO values should be obtained consistently either pre- and at a specific time postalbuterol treatment or spirometry. Alternatively, changes in FENO values should be interpreted in relationship to the timing of these maneuvers. Pediatr Pulmonol. 2002; 34:203–208.Keywords
This publication has 19 references indexed in Scilit:
- Exhaled Nitric Oxide Following Repeated Spirometry or Repeated Plethysmography in Healthy IndividualsAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Respiratory Effects of Environmental Tobacco Smoke in a Panel Study of Asthmatic and Symptomatic ChildrenAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric Oxide and Nasal Nitric Oxide in Adults and Children—1999American Journal of Respiratory and Critical Care Medicine, 1999
- Exhaled Nitric Oxide after β2-agonist Inhalation and Spirometry in AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Expired Nitric Oxide after Bronchoprovocation and Repeated Spirometry in Patients with AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Corticosteroids decrease exhaled nitric oxide in children with acute asthmaThe Journal of Pediatrics, 1997
- Effect of short- and long-acting inhaled beta2-agonists on exhaled nitric oxide in asthmatic patientsEuropean Respiratory Journal, 1997
- Exhaled nitric oxide during acute changes of airways calibre in asthmaEuropean Respiratory Journal, 1996
- Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients.American Journal of Respiratory and Critical Care Medicine, 1996
- Statement on Standards for the Diagnosis and Care of Patients with Chronic Obstructive Pulmonary Disease (COPD) and AsthmaAmerican Review of Respiratory Disease, 1987